Advertisement

Medical, Nonmedical, and Illegal Stimulant Use by Sexual Identity and Gender

Published:September 24, 2020DOI:https://doi.org/10.1016/j.amepre.2020.05.025

      Introduction

      Major knowledge gaps regarding medical and nonmedical prescription stimulant use and illegal stimulant use (i.e., cocaine/crack/methamphetamine) by sexual identity and gender have implications for individuals’ health and well-being. This study improves stimulant use measurement by differentiating the type of stimulant use and focusing on lesbian, gay, and bisexual subpopulations.

      Methods

      Data were pooled for adults in the 2015–2017 National Survey on Drug Use and Health (n=126,463; analyzed in 2019). Gender-stratified logistic regression models examined associations between sexual identity and past-year illegal stimulant use. Gender-stratified multinomial logistic regression models estimated odds of (1) medical use only versus no past-year prescription stimulant use, (2) any nonmedical stimulant use versus no past-year use, and (3) any nonmedical stimulant use versus medical use only.

      Results

      Illegal stimulant use varied by sexual identity (men: gay, 9.2%; bisexual, 7.5%; heterosexual, 3.2%; women: gay/lesbian, 3.2%; bisexual, 7.8%; heterosexual, 1.5%), as did nonmedical prescription stimulant use. Relative to same-gender heterosexuals, gay (AOR=2.61, 95% CI=2.00, 3.40) and bisexual (AOR=1.70, 95% CI=1.24, 2.33) men had higher odds of past-year illegal stimulant use, as did gay/lesbian (AOR=1.63, 95% CI=1.16, 2.28) and bisexual (AOR=2.70, 95% CI=2.23, 3.26) women. Sexual minorities reported higher odds of nonmedical prescription stimulant use than heterosexuals. Any nonmedical prescription opioid use was reported by 26.4% of people who reported nonmedical stimulant use and 27.0% of people who reported illegal stimulant use.

      Conclusions

      Lesbian, gay, and bisexual individuals had a higher prevalence of stimulant use than their heterosexual counterparts. This has important implications for health disparities, especially given the high levels of polysubstance use. Taking a multilevel approach is crucial to reduce stimulant-related harms for lesbian, gay, and bisexual individuals.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      REFERENCES

        • Arria AM
        • DuPont RL
        Prescription stimulant use and misuse: implications for responsible prescribing practices.
        Am J Psychiatry. 2018; 175: 707-708
        • Piper BJ
        • Ogden CL
        • Simoyan OM
        • et al.
        Trends in use of prescription stimulants in the United States and Territories, 2006 to 2016.
        PLoS One. 2018; 13e0206100
        • Safer DJ.
        Recent trends in stimulant usage.
        J Atten Disord. 2016; 20: 471-477
        • Han B
        • Jones CM
        • Blanco C
        • Compton WM
        National trends in and correlates of nonmedical use of prescription stimulants, nonmedical use frequency, and use disorders.
        J Clin Psychiatry. 2017; 78: e1250-e1258
        • Molina BSG
        • Hinshaw SP
        • Eugene Arnold L
        • et al.
        Adolescent substance use in the multimodal treatment study of attention-deficit/hyperactivity disorder (ADHD) (MTA) as a function of childhood ADHD, random assignment to childhood treatments, and subsequent medication.
        J Am Acad Child Adolesc Psychiatry. 2013; 52: 250-263
        • Schachar RJ
        • Tannock R
        • Cunningham C
        • Corkum PV
        Behavioral, situational, and temporal effects of treatment of ADHD with methylphenidate.
        J Am Acad Child Adolesc Psychiatry. 1997; 36: 754-763
        • Nissen SE
        ADHD drugs and cardiovascular risk.
        N Engl J Med. 2006; 354: 1445-1448
        • Chen LY
        • Strain EC
        • Alexandre PK
        • Alexander GC
        • Mojtabai R
        • Martins SS
        Correlates of nonmedical use of stimulants and methamphetamine use in a national sample.
        Addict Behav. 2014; 39: 829-836
        • Johnston LD
        • O'Malley PM
        • Miech RA
        • Bachman JG
        • Schulenberg JE
        Monitoring the Future National Survey Results on Drug Use, 1975-2015: 2018 Overview, Key Findings on Adolescent Drug Use.
        Institute for Social Research, Ann Arbor, MI2019
        • McCabe SE
        • Teter CJ
        • Boyd CJ
        • Wilens TE
        • Schepis TS
        Sources of prescription medication misuse among young adults in the United States: the role of educational status.
        J Clin Psychiatry. 2018; 79: 17m11958
        • Benson K
        • Flory K
        • Humphreys KL
        • Lee SS
        Misuse of stimulant medication among college students: a comprehensive review and meta-analysis.
        Clin Child Fam Psychol Rev. 2015; 18: 50-76
        • DeSantis AD
        • Webb EM
        • Noar SM
        Illicit use of prescription ADHD medications on a college campus: a multimethodological approach.
        J Am Coll Health. 2008; 57: 315-324
        • Dussault CL
        • Weyandt LL.
        An examination of prescription stimulant misuse and psychological variables among sorority and fraternity college populations.
        J Atten Disord. 2013; 17: 87-97
        • Arria AM
        • Wilcox HC
        • Caldeira KM
        • Vincent KB
        • Garnier-Dykstra LM
        • O'Grady KE
        Dispelling the myth of “smart drugs”: cannabis and alcohol use problems predict nonmedical use of prescription stimulants for studying.
        Addict Behav. 2013; 38: 1643-1650
        • Pilkinton M
        • Cannatella A
        Nonmedical use of prescription stimulants: age, race, gender, and educational attainment patterns.
        J Hum Behav Soc Environ. 2012; 22: 409-420
        • Partridge BJ
        • Bell SK
        • Lucke JC
        • Yeates S
        • Hall WD
        Smart drugs “as common as coffee”: media hype about neuroenhancement.
        PLoS One. 2011; 6: e28416
        • Arria AM
        • Caldeira KM
        • O'Grady KE
        • Vincent KB
        • Johnson EP
        • Wish ED
        Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use.
        Pharmacotherapy. 2008; 28: 156-169
        • McCabe SE
        • Knight JR
        • Teter CJ
        • Wechsler H
        Non-medical use of prescription stimulants among U.S. college students: prevalence and correlates from a national survey [published correction appears in Addiction. 2005;100(4):573].
        Addiction. 2005; 100: 96-106
        • National Institute on Drug Abuse, NIH, HHS
        Prescription stimulants drugfacts: what are prescription stimulants?.
        National Institute on Drug Abuse, NIH, HHS, North Bethesda, MD2018 (Published)
        • Arria AM
        • DuPont RL
        Nonmedical prescription stimulant use among college students: why we need to do something and what we need to do.
        J Addict Dis. 2010; 29: 417-426
        • Barrett SP
        • Darredeau C
        • Bordy LE
        • Pihl RO
        Characteristics of methylphenidate misuse in a university student sample.
        Can J Psychiatry. 2005; 50: 457-461
        • Sweeney CT
        • Sembower MA
        • Ertischek MD
        • Shiffman S
        • Schnoll SH
        Nonmedical use of prescription ADHD stimulants and preexisting patterns of drug abuse.
        J Addict Dis. 2013; 32: 1-10
        • Substance Abuse and Mental Health Services Administration
        Key Substance use and mental health indicators in the United States: results from the 2017 National Survey on Drug Use and Health.
        Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD2018 (Published)
        • Durell TM
        • Kroutil LA
        • Crits-Christoph P
        • Barchha N
        • Van Brunt DL
        Prevalence of nonmedical methamphetamine use in the United States.
        Subst Abuse Treat Prev Policy. 2008; 3: 19
        • Bourne A
        • Reid D
        • Hickson F
        • Torres-Rueda S
        • Weatherburn P
        Illicit drug use in sexual settings (‘chemsex’) and HIV/STI transmission risk behaviour among gay men in South London: findings from a qualitative study.
        Sex Transm Infect. 2015; 91: 564-568
        • DeSimone J
        Illegal drug use and employment.
        J Labor Econ. 2002; 20: 952-977
        • Degenhardt L
        • Hall W
        Extent of illicit drug use and dependence, and their contribution to the global burden of disease.
        Lancet. 2012; 379: 55-70
        • LaRue L
        • Twillman RK
        • Dawson E
        • et al.
        Rate of fentanyl positivity among urine drug test results positive for cocaine or methamphetamine [published correction appears in JAMA Netw Open 2019;2(10):e1916040].
        JAMA Netw Open. 2019; 2e192851
        • McCabe SE
        • West BT
        • Hughes TL
        • Boyd CJ
        Sexual orientation and substance abuse treatment utilization in the United States: results from a national survey.
        J Subst Abuse Treat. 2013; 44: 4-12
        • Schuler MS
        • Rice CE
        • Evans-Polce RJ
        • Collins RL
        Disparities in substance use behaviors and disorders among adult sexual minorities by age, gender, and sexual identity.
        Drug Alcohol Depend. 2018; 189: 139-146
        • Zaza S
        • Kann L
        • Barrios LC
        Lesbian, gay, and bisexual adolescents: population estimate and prevalence of health behaviors.
        JAMA. 2016; 316: 2355-2356
        • Medley G
        • Lipari R
        • Bose J
        • Cribb DS
        • Kroutil LA
        • McHenry G
        Sexual orientation and estimates of adult substance use and mental health: results from the 2015 National Survey on Drug Use and Health.
        Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health, Rockville, MD2016 (Published)
        • Meyer IH
        Prejudice, social stress, and mental health in lesbian, gay, and bisexual populations: conceptual issues and research evidence.
        Psychol Bull. 2003; 129: 674-697
        • Lea T
        • de Wit J
        • Reynolds R
        Minority stress in lesbian, gay, and bisexual young adults in Australia: associations with psychological distress, suicidality, and substance use.
        Arch Sex Behav. 2014; 43: 1571-1578
        • Friedman MR
        • Dodge B
        • Schick V
        • et al.
        From bias to bisexual health disparities: attitudes toward bisexual men and women in the United States.
        LGBT Health. 2014; 1: 309-318
        • Roberts TS
        • Horne SG
        • Hoyt WT
        Between a gay and a straight place: bisexual individuals’ experiences with monosexism.
        J Bisexuality. 2015; 15: 554-569
        • Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration
        Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health.
        Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration, Rockville, MD2015 (Published)
        • Kerr DL
        • Ding K
        • Chaya J
        Substance use of lesbian, gay, bisexual and heterosexual college students.
        Am J Health Behav. 2014; 38: 951-962
        • Shadick R
        • Dagirmanjian FB
        • Trub L
        • Dawson H
        Sexual orientation and first-year college students’ nonmedical use of prescription drugs.
        J Am Coll Health. 2016; 64: 292-299
        • Kecojevic A
        • Corliss HL
        • Lankenau SE
        Motivations for prescription drug misuse among young men who have sex with men (YMSM) in Philadelphia.
        Int J Drug Policy. 2015; 26: 764-771
        • Newcomb ME
        • Ryan DT
        • Greene GJ
        • Garofalo R
        • Mustanski B
        Prevalence and patterns of smoking, alcohol use, and illicit drug use in young men who have sex with men.
        Drug Alcohol Depend. 2014; 141: 65-71
        • McCabe SE
        • Hughes TL
        • Bostwick WB
        • West BT
        • Boyd CJ
        Sexual orientation, substance use behaviors and substance dependence in the United States.
        Addiction. 2009; 104: 1333-1345
        • Li DH
        • Turner BC
        • Mustanski B
        • Phillips GL
        Sexual orientation disparities in prescription drug misuse among a nationally representative sample of adolescents: prevalence and correlates.
        Addict Behav. 2018; 77: 143-151
        • Hatzenbuehler ML
        Structural stigma and the health of lesbian, gay, and bisexual populations.
        Curr Dir Psychol Sci. 2014; 23: 127-132
        • Center for Behavioral Health Statistics and Quality
        2017 National survey on drug use and health: methodological summary and definitions.
        Substance Abuse and Mental Health Services Administration, Rockville, MD2018 (Published)
        • Lehavot K
        • Simoni JM
        The impact of minority stress on mental health and substance use among sexual minority women.
        J Consult Clin Psychol. 2011; 79: 159-170
        • Mereish EH
        • Goldbach JT
        • Burgess C
        • DiBello AM
        Sexual orientation, minority stress, social norms, and substance use among racially diverse adolescents.
        Drug Alcohol Depend. 2017; 178: 49-56
        • Feinstein BA
        • Dyar C
        Bisexuality, minority stress, and health.
        Curr Sex Health Rep. 2017; 9: 42-49
        • Plankey MW
        • Ostrow DG
        • Stall R
        • et al.
        The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study.
        J Acquir Immune Defic Syndr. 2007; 45: 85-92
        • Colfax G
        • Coates TJ
        • Husnik MJ
        • et al.
        Longitudinal patterns of methamphetamine, popper (amyl nitrite), and cocaine use and high-risk sexual behavior among a cohort of San Francisco men who have sex with men.
        J Urban Health. 2005; 82: i62-i70
        • Swartz JA
        • McCarty-Caplan D
        A study of the longitudinal patterns of stimulant and amyl nitrite use and sexual behavior pre- and post-HIV seroconversion among MSM.
        AIDS Behav. 2018; 22: 1395-1409
        • Kelly BC
        • Parsons JT
        Prevalence and predictors of non-medical prescription drug use among men who have sex with men.
        Addict Behav. 2010; 35: 312-317
        • Benotsch EG
        • Martin AM
        • Koester S
        • Cejka A
        • Luckman D
        Nonmedical use of prescription drugs and HIV risk behavior in gay and bisexual men.
        Sex Transm Dis. 2011; 38: 105-110
        • Schuler MS
        • Collins RL
        Sexual minority substance use disparities: bisexual women at elevated risk relative to other sexual minority groups.
        Drug Alcohol Depend. 2020; 206107755
        • Philbin MM
        • Mauro PM
        • Greene ER
        • Martins SS
        State-level marijuana policies and marijuana use and marijuana use disorder among a nationally representative sample of adults in the United States, 2015-2017: sexual identity and gender matter.
        Drug Alcohol Depend. 2019; 204107506
        • Cochran SD
        • Ackerman D
        • Mays VM
        • Ross MW
        Prevalence of non-medical drug use and dependence among homosexually active men and women in the U.S. population.
        Addiction. 2004; 99: 989-998
        • Kecojevic A
        • Wong CF
        • Corliss HL
        • Lankenau SE
        Risk factors for high levels of prescription drug misuse and illicit drug use among substance-using young men who have sex with men (YMSM).
        Drug Alcohol Depend. 2015; 150: 156-163
        • Gerrard M
        • Stock ML
        • Roberts ME
        • et al.
        Coping with racial discrimination: the role of substance use.
        Psychol Addict Behav. 2012; 26: 550-560
        • Mauro PM
        • Philbin MM
        • Greene E
        • Martins SS
        Gender and sexual identity differences in prescription opioid use by medical marijuana law status in the United States.
        in: Paper presented at: Poster Session at the 11th International Women's and Children's Health and Gender (InWomen's) Group Conference, San Antonio, TXJune 14, 2019
        • Centers for Disease Control and Prevention
        2018 Annual surveillance report of drug-related risks and outcomes, United States.
        Centers for Disease Control and Prevention, HHS, Atlanta, GA2018
        • Seth P
        • Scholl L
        • Rudd RA
        • Bacon S
        Overdose deaths involving opioids, cocaine, and psychostimulants - United States, 2015-2016.
        MMWR Morb Mortal Wkly Rep. 2018; 67: 349-358
        • Peterson AB
        • Gladden RM
        • Delcher C
        • et al.
        Increases in fentanyl-related overdose deaths - Florida and Ohio, 2013-2015.
        MMWR Morb Mortal Wkly Rep. 2016; 65: 844-849
        • Daniulaityte R
        • Juhascik MP
        • Strayer KE
        • et al.
        Trends in fentanyl and fentanyl analogue-related overdose deaths - Montgomery County, Ohio, 2015-2017.
        Drug Alcohol Depend. 2019; 198: 116-120
        • Nolan ML
        • Shamasunder S
        • Colon-Berezin C
        • Kunins HV
        • Paone D
        Increased presence of fentanyl in cocaine-involved fatal overdoses: implications for prevention.
        J Urban Health. 2019; 96: 49-54
        • Manz J
        Federal funding change that includes stimulants allows states to expand their substance use disorder initiatives.
        National Academy for State Health Policy, Washington, DC2020
        • Hatzenbuehler ML
        • Jun HJ
        • Corliss HL
        • Bryn Austin SB
        Structural stigma and sexual orientation disparities in adolescent drug use.
        Addict Behav. 2015; 46: 14-18
        • Dowell D
        • Zhang K
        • Noonan RK
        • Hockenberry JM
        Mandatory provider review and pain clinic laws reduce the amounts of opioids prescribed and overdose death rates.
        Health Aff (Millwood). 2016; 35: 1876-1883
        • Meara E
        • Horwitz JR
        • Powell W
        • et al.
        State legal restrictions and prescription-opioid use among disabled adults.
        N Engl J Med. 2016; 375: 44-53
        • Steenkamp JEM
        • De Jong MG
        • Baumgartner H
        Socially desirable response tendencies in survey research.
        J Mark Res. 2010; 47: 199-214
      1. HHS, Substance Abuse and Mental Health Services Administration. Learning from the field: programs serving youth who are LGBTQI2-S and experiencing homelessness. Rockville, MD: HHS, Substance Abuse and Mental Health Services Administration. http://www.samhsa.gov/sites/default/files/programs_campaigns/homelessness_programs_resources/learning-field-programs-serving-youth-lgbtqi2s-experiencing-homelessness.pdf. Accessed June 9, 2020.

      2. Draft recommendation. United States Preventive Services Task Force.https://www.uspreventiveservicestaskforce.org/uspstf/announcements/final-research-plan-screening-drug-use-adolescents-and-adults-including-pregnant-women. Accessed January 27, 2020.

        • Mauro PM
        • Samples H
        • Klein KS
        • Martins SS
        Discussing drug use with health care providers is associated with perceived need and receipt of drug treatment among adults in the United States: we need to talk.
        Med Care. 2020; 58: 617-624
        • Philbin MM
        • Mauro PM
        Measuring polysubstance use over the life course: implications for multilevel interventions.
        Lancet Psychiatry. 2019; 6: 797-798
        • Peiper NC
        • Clarke SD
        • Vincent LB
        • Ciccarone D
        • Kral AH
        • Zibbell JE
        Fentanyl test strips as an opioid overdose prevention strategy: findings from a syringe services program in the Southeastern United States.
        Int J Drug Policy. 2019; 63: 122-128